|
BBS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04458672214969E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.09083877883631E-12 |
| Normal-vs-Stage2 |
7.97806265495637E-12 |
| Normal-vs-Stage3 |
1.74893433069201E-12 |
| Normal-vs-Stage4 |
1.85074178205014E-13 |
| Stage1-vs-Stage2 |
2.288400E-01 |
| Stage1-vs-Stage3 |
8.611900E-02 |
| Stage1-vs-Stage4 |
6.427800E-02 |
| Stage2-vs-Stage3 |
9.481800E-01 |
| Stage2-vs-Stage4 |
6.233400E-01 |
| Stage3-vs-Stage4 |
6.251200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1218582446636E-12 |
| Normal-vs-AfricanAmerican |
1.00110000289533E-08 |
| Normal-vs-Asian |
2.19630003073235E-09 |
| Caucasian-vs-AfricanAmerican |
8.768200E-01 |
| Caucasian-vs-Asian |
3.934800E-01 |
| AfricanAmerican-vs-Asian |
6.720000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89768209427166E-14 |
| Normal-vs-Female |
1.55842005966633E-12 |
| Male-vs-Female |
6.514100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.09540196094827E-11 |
| Normal-vs-Age(41-60Yrs) |
1.69975145070111E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63191682389652E-12 |
| Normal-vs-Age(81-100Yrs) |
2.475400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.291790E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.038470E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.306400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.397200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.763000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.457240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.682000E-01 |
| Classical-VS-Follicular |
1.814500E-02 |
| Classical-VS-Other |
3.197600E-01 |
| Classical-VS-Normal |
3.58350016327336E-11 |
| Tall-VS-Follicular |
6.913200E-01 |
| Tall-VS-Other |
6.726800E-01 |
| Tall-VS-Normal |
1.23509980021197E-10 |
| Follicular-VS-Other |
8.524800E-01 |
| Follicular-VS-Normal |
1.99906757814006E-12 |
| Other-VS-Normal |
4.613100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23234755733392E-13 |
| Normal-vs-N1 |
7.38069605432656E-11 |
| N0-vs-N1 |
7.580800E-01 |
|
|
